![](/img/cover-not-exists.png)
Analysis of progression patterns and failure sites of metastatic lung adenocarcinoma patients with EGFR mutations receiving first-line treatment of tyrosine kinase inhibitors
Li, Xiao-yang, Zhu, Xue-ru, Zhang, Chen-chen, Yu, Wen, Zhang, Bo, Shen, Tian-le, Zhang, Hong-yan, Fu, Xiao-longJournal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2020.04.004
Date:
April, 2020
File:
PDF, 2.52 MB
2020